WANRI Director and WA research team join with US pharmaceuticals company to improve drug treatment

WANRI Director and WA research team join with US pharmaceuticals company to improve drug treatment
Posted on October 2, 2015
Professor Steve Wilton, WA Neuroscience Research Institute (WANRI) Director, and Professor Sue Fletcher, both based at the Centre for Comparative Genomics, lead the research team at Murdoch University which has signed a four-year agreement with Sarepta Pharmaceuticals that will see the type of drugs developedĀ to treat Duchenne Muscular Dystrophy (DMD) patients being redesigned into solutions for people with other genetic diseases.

Please visitĀ https://www.wanri.org/wanri-director-and-wa-research-team-join-with-us-pharmaceuticals-company-to-improve-treatment/ to read the full article.